Gender differences in drug toxicity

Trends in Pharmacological Sciences
Tamara J NicolsonRuth R A Roberts

Abstract

Clinical data suggest that gender dimorphic profiles are emerging in terms of both drug efficacy and adverse drug reactions (ADRs). With an increasing emphasis on individualised therapies and the need to prevent drug attrition there is a compelling need to understand the molecular basis for gender dimorphic profiles in ADRs and the consequences. Classes of agents exhibiting gender-based variation in pharmaceutical efficacy and toxicity include anaesthetics, HIV-1 therapies and antiarrhythmic drugs. Body weight differences are often cited as a reason for differences in drug pharmacokinetics and subsequent toxicity. However, some studies accounted for these factors and still found significance suggesting that dosage versus body weight does not explain the outcome. Here, we present an overview of current understanding of gender-specific drug toxicity and present rational molecular explanations for these adverse events. There is mounting evidence in support of hormonal effects underpinning the majority of the ADR differences observed between the sexes.

References

Jul 22, 1992·Biochemical Pharmacology·C M HuntG M Stave
Mar 1, 1981·British Journal of Clinical Pharmacology·P A RoutledgeD G Shand
Dec 1, 1993·JAMA : the Journal of the American Medical Association·R R MakkarM H Lehmann
Dec 1, 1995·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·R MeierR Brignoli
Aug 1, 1997·The Journal of General Physiology·B D JohnsonG M Rubanyi
Dec 8, 1998·JAMA : the Journal of the American Medical Association·M D DriciR L Woosley
Dec 3, 1999·Journal of Clinical Pharmacy and Therapeutics·E Tanaka
Feb 15, 2000·British Journal of Clinical Pharmacology·D S Ou-YangH H Zhou
Jul 7, 2000·Journal of Clinical Pharmacology·G H KamimoriN D Eddington
Aug 18, 2000·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·S KatoJ Yanagisawa
Oct 6, 2000·Clinical Pharmacokinetics·G Cheymol
Mar 20, 2001·JAMA : the Journal of the American Medical Association·I RodriguezR L Woosley
Nov 7, 2001·European Journal of Drug Metabolism and Pharmacokinetics·R SchmidtR Preiss
May 31, 2002·Clinical Pharmacokinetics·Bernd MeibohmHartmut Derendorf
Aug 7, 2002·Clinical Pharmacokinetics·Michael S RobertsMichael Weiss
Sep 5, 2003·Journal of Clinical Pharmacology·Richard Judson
Mar 5, 2004·The New England Journal of Medicine·Dan M Roden
May 6, 2004·Cancer Research·Yuki TsuchiyaTsuyoshi Yokoi
Sep 15, 2004·Zeitschrift für Kardiologie·S KääbE Schulze-Bahr
Nov 13, 2004·The Journal of Biological Chemistry·Christopher A Wiwi, David J Waxman
Nov 19, 2004·Biochemical Pharmacology·Margit FröhlichJohanna Weiss
May 10, 2005·Journal of Cardiovascular Electrophysiology·Arash Arya
Nov 18, 2005·The Journal of Pharmacology and Experimental Therapeutics·Connie CheungFrank J Gonzalez
Feb 17, 2006·European Journal of Pharmacology·Clemens Möller, Rainer Netzer
Mar 18, 2006·Molecular Endocrinology·David J Waxman, Caitlin O'Connor
May 11, 2006·Drug Metabolism Reviews·Agneta Mode, Jan-Ake Gustafsson
Jun 13, 2006·Clinical Pharmacology and Therapeutics·A TranJ M Tréluyer
Jul 27, 2006·Expert Opinion on Drug Metabolism & Toxicology·Obiamiwe C Umeh, Judith S Currier
Dec 5, 2006·Current Opinion in Cardiology·Prince J Kannankeril, Dan M Roden
Aug 21, 2007·Gender Medicine·Ighovwerha OfotokunJane E Hitti
Nov 3, 2007·The Journal of Clinical Investigation·Kenneth E Thummel
Mar 15, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tadahiro HashitaNobuo Nemoto
May 17, 2008·Molecular Endocrinology·Valerie Wauthier, David J Waxman
Jun 25, 2008·Gender Medicine·Raymond HreicheJacques Turgeon

❮ Previous
Next ❯

Citations

Mar 16, 2011·Journal of Biomedicine & Biotechnology·Offie P SoldinDonald R Mattison
May 18, 2012·AIDS Research and Treatment·Lycely Del C Sepúlveda-TorresLuis A Cubano
Jan 17, 2013·World Journal of Gastroenterology : WJG·Zuzana ZelinkovaC Janneke van der Woude
Feb 27, 2013·Indian Journal of Pharmaceutical Sciences·M M Abukhader
Jan 5, 2011·Expert Opinion on Drug Metabolism & Toxicology·Nikolaos KokrasZeta Papadopoulou-Daifoti
Sep 6, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Belen EguiaJacques Cadranel
Jun 5, 2012·Neurotoxicology·Bernard Weiss
Jun 7, 2011·International Journal of Pharmaceutics·Ana C FreireHamid A Merchant
Dec 15, 2010·British Journal of Clinical Pharmacology·Eline M RodenburgLoes E Visser
May 18, 2012·British Journal of Clinical Pharmacology·Rashmi R Shah, Devron R Shah
Apr 16, 2011·The Journal of Pharmacy and Pharmacology·Ballent MarianaLanusse Carlos
Sep 7, 2012·Health Physics·Daniela Stricklin, Kyle Millage
Oct 23, 2015·Metabolomics : Official Journal of the Metabolomic Society·Jan KrumsiekGabi Kastenmüller
Apr 22, 2015·Basic & Clinical Pharmacology & Toxicology·Els Van PeerSteven Van Cruchten
Mar 10, 2015·Biology of Sex Differences·Stancy JosephBeverly Lyn-Cook
Sep 13, 2014·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Günay KirkimHülya Ellidokuz
Jun 7, 2011·Neurotoxicology·Jennifer L MadisonAaron B Bowman
Oct 19, 2011·Toxicology Mechanisms and Methods·Wardah Yusof, Gan Siew Hua
Mar 29, 2014·Toxicology and Applied Pharmacology·Tarjinder SahotaOscar Della Pasqua
May 8, 2016·Alcoholism, Clinical and Experimental Research·Marina GuizzettiFarida Sohrabji
Feb 1, 2013·Current Urology·Phani B Patra, Sayani Patra
Dec 24, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Howard R MellorRuth R A Roberts
Apr 17, 2014·Experimental Biology and Medicine·Sharon L EddieJoanna E Burdette
Mar 23, 2017·European Heart Journal. Cardiovascular Pharmacotherapy·J TamargoS Agewall
Apr 6, 2017·Archives of Gynecology and Obstetrics·Md Mohaimenul IslamShabbir Syed-Abdul
Jan 13, 2018·Basic & Clinical Pharmacology & Toxicology·Carmen BelmonteFrancisco Abad-Santos
Jul 14, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Berna C ÖzdemirAnna Dorothea Wagner
Nov 9, 2018·The Laryngoscope·Elizabeth D StephensonAdam M Zanation
Jan 3, 2019·Journal of Women's Health·Gillian A BeauchampMarna Rayl Greenberg
Mar 24, 2020·Applied Neuropsychology. Child·Alicia NuñezDaniel N Allen
Jul 9, 2016·Clinical Science·Morgane GriesbeckMarcus Altfeld
Sep 22, 2018·The Pharmacogenomics Journal·Sijia YanQinghe Xing

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Expert Review of Clinical Pharmacology
Ameeta ParekhDouglas C Throckmorton
Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Flavia FranconiVincenzo Cuomo
European Journal of Clinical Pharmacology
Y ZopfH Dormann
Clinical Pharmacokinetics
Janice B Schwartz
© 2021 Meta ULC. All rights reserved